| 股票 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 荣昌生物 688331 | 生物制品 | 12.0 | 18.0 | — | 8.44 | — | — | 80% | 29% | 0.1 | 6.2% | +62% | +158% | +60% | +51% | -36% | 70% | 701 |
| 君实生物 688180 | 生物制品 | — | — | — | 5.78 | — | — | 69% | 35% | — | -3.1% | +20% | +25% | -2% | -28% | -41% | 48% | 344 |
| 长春高新 000661 | 生物制品 | — | 26.8 | 1.28 | 1.34 | 0.2% | 40% | 86% | 33% | 1.8 | -2.1% | -2% | -4% | -20% | -30% | -54% | 40% | 301 |
| 神州细胞 688520 | 生物制品 | — | — | — | — | — | — | 96% | 40% | — | -3.0% | +15% | +20% | -20% | -50% | -50% | 43% | 162 |
| 泰诺麦博 688806 | 生物制品 | — | — | — | 206.60 | — | — | 36% | 14% | — | -4.8% | — | — | — | — | -49% | 112% | 106 |
| 诺唯赞 688105 | 生物制品 | — | 78.0 | 1.59 | 2.79 | 2.0% | — | 70% | 9% | 5.3 | 2.1% | -27% | -9% | +30% | -0% | -32% | 54% | 101 |
| 智翔金泰 688443 | 生物制品 | — | — | — | 6.65 | — | — | 50% | 17% | — | -8.1% | +686% | +9% | -15% | -33% | -44% | 44% | 85 |
| 百奥泰 688177 | 生物制品 | — | — | — | 58.40 | — | — | 73% | 44% | — | -2.3% | +27% | +19% | -24% | -46% | -54% | 40% | 72 |
| 艾迪药业 688488 | 生物制品 | — | 140.4 | 1.11 | 7.10 | — | — | 46% | 20% | 5.6 | -0.6% | +43% | +108% | -6% | -15% | -48% | 60% | 65 |
| 诺思兰德 920047 | 生物制品 | — | — | — | 17.88 | — | — | 56% | 48% | — | -1.9% | +1% | +106% | -32% | — | — | — | 44 |
| 近岸蛋白 688137 | 生物制品 | — | — | — | 2.17 | — | 278% | 76% | 8% | — | -2.3% | -18% | +21% | +55% | +36% | -38% | 68% | 43 |
| 赛升药业 300485 | 生物制品 | — | — | — | 1.30 | 0.3% | 55% | 70% | 13% | 0.6 | -1.9% | -18% | +51% | -18% | -40% | -42% | 48% | 42 |
| 科兴制药 688136 | 生物制品 | 19.6 | 23.9 | 0.92 | 2.24 | 1.2% | 66% | 71% | 29% | 17.9 | -0.2% | +5% | +46% | -35% | -55% | -62% | 54% | 41 |
| 四环生物 000518 | 生物制品 | — | — | — | 13.00 | — | — | 69% | 11% | — | 0.2% | +8% | -5% | +62% | +55% | -32% | 45% | 40 |
| *ST未名 002581 | 生物制品 | — | — | — | 2.09 | — | — | 79% | 17% | — | -9.4% | -8% | -30% | -25% | -23% | -65% | 52% | 37 |
| 优宁维 301166 | 生物制品 | — | — | — | 1.27 | 2.1% | 146% | 20% | 12% | — | -5.4% | -3% | +6% | -2% | -14% | -29% | 38% | 25 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。